The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results of the international, expanded-access program of everolimus in patients with advanced renal cell carcinoma who progress after prior vascular endothelial growth factor receptor–tyrosine kinase inhibitor (VEGFr-TKI) therapy.
V. Gr├╝nwald
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - Pfizer
Other Remuneration - GlaxoSmithKline; Novartis; Pfizer
P. I. Karakiewicz
Honoraria - Bayer; Novartis; Pfizer; Roche
S. E. Bavbek
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer; Sanofi
K. Miller
Consultant or Advisory Role - Novartis
Honoraria - Novartis
J. H. Machiels
No relevant relationships to disclose
S. Lee
Consultant or Advisory Role - Novartis
Expert Testimony - Novartis
J. M. G. Larkin
Consultant or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis
Research Funding - Bayer; Novartis; Pfizer
P. Bono
Expert Testimony - Novartis (U)
S. Y. Rha
Consultant or Advisory Role - Novartis
D. E. Castellano
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - GlaxoSmithKline; Novartis; Pfizer; Roche
Research Funding - Pfizer
Other Remuneration - GlaxoSmithKline; Novartis; Pfizer
C. U. Blank
Consultant or Advisory Role - Novartis
Other Remuneration - Novartis
J. J. Knox
Research Funding - Bayer; Novartis; Pfizer
R. Hawkins
Honoraria - Novartis
R. R. Yuan
Stock Ownership - Novartis
M. Rosamilia
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
J. L. Booth
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
I. Bodrogi
No relevant relationships to disclose